A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis

Rheumatology

Volumn 39, Issue 1, 2000, Pages 63-66

  Barton, A ^a   Myerscough, A ^a   John, S ^a   Gonzalez Gay, M ^b   Oilier, W ^a   Worthington, J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOSPITAL XERAL CALDE   (Spain)

Author keywords

Autoimmunity; CTLA 4; Genetic; Rheumatoid arthritis; SNP; Susceptibility locus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UNITED KINGDOM;

EID: 0033982088     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.1.63     Document Type: Article

References (14)

1. Silman AJ, MacGregor AJ, Thomson W et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993;32:903-7.
2. MacGregor AJ, Rigby AS, Oilier WER, Silman AJ. An estimation of the relative genetic and environmental contribution to rheumatoid arthritis based on covariance analysis of twin data, Br J Rheumatol 1994;33(suppl. 1):1583.
3. John S, Hajeer A, Marlow A et al. Investigation of candidate disease susceptibility genes in rheumatoid arthritis: principles and strategies. J Rheumatol 1997;24: 199-201.
4. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-8.
5. Nistico L, Buzzetti R, Pritchard L et al. The CTLA-4 gene region of chromosome 2q33 is linked to and associated with type I diabetes. Hum Mol Genet 1996;5:1075-86.
6. Harper K, Balzano C, Rouvier E, Mattel MG, Luciani MF, Goldstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. J Immunol 1991;147:1037-44.
7. Donner H, Rau H, Walfish PG et al. CTLA-4 alanine-17 confers genetic susceptibility to Graves disease and to type I diabetes mellitus. J Clin Endocrinol Metab 1997;82:143-6.
8. Yanagawa T, Hidaka Y, Guimaraes V et al. CTLA-4 gene polymorphism associated with Graves disease in a Caucasian population. J Clin Endocrinol Metab 1995;80: 41-5.
9. Seidl C, Donner H, Fischer B et al. CTLA-4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998;51:62-6.
10. Forre O, Vinje O, Flate B et al. CTLA-4 polymorphism and susceptibility to juvenile rheumatoid arthritis (JRA). Arthritis Rheum 1997;40(suppl):Abstract no. 1264.
11. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Lorber M, Gershwin ME, Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthritis Rheum 1994;24:105-13.
13. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-8.
14. Yelamos J, Garcia-Lozano JR, Moreno I et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993;36:811-4.